CNS Pharmaceuticals (CNSP)

• Market cap: $6.77M
• 1 day: -2.32%
• 5 days: 0.87%
• 1 month: -1.7%
• 3 months: 88.98%
• 6 months: -37.35%
• Year to date: -12.64%
• 1 year: -52.42%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Employees: 8